GPT and metabolic dysfunction-associated steatohepatitis: In addition, the patients with non-alcoholic steatohepatitis administrated Met for 48 weeks increased the proportion of patients with normal ALT levels; however, treatment did not affect the proportion of patients with normal AST levels [35].